CHARLTON ARIA ACQUISITI-CL A (CHAR) Stock Fundamental Analysis

NASDAQ:CHAR • KYG9877L1077

10.53 USD
-0.01 (-0.09%)
Last: Feb 12, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CHAR. CHAR was compared to 0 industry peers in the Unkown industry. The financial health of CHAR is average, but there are quite some concerns on its profitability. CHAR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year CHAR was profitable.
CHAR Yearly Net Income VS EBIT VS OCF VS FCFCHAR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2024 0 200K -200K -400K

1.2 Ratios

Industry RankSector Rank
ROA 3.27%
ROE 3.33%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CHAR Yearly ROA, ROE, ROICCHAR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2024 0 0.2 -0.2 -0.4

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for CHAR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CHAR Yearly Profit, Operating, Gross MarginsCHAR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • CHAR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CHAR Yearly Shares OutstandingCHAR Yearly Shares OutstandingYearly Shares Outstanding 2024 2M 4M 6M 8M 10M
CHAR Yearly Total Debt VS Total AssetsCHAR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2024 20M 40M 60M 80M

2.2 Solvency

  • CHAR has an Altman-Z score of 39.64. This indicates that CHAR is financially healthy and has little risk of bankruptcy at the moment.
  • There is no outstanding debt for CHAR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 39.64
ROIC/WACCN/A
WACCN/A
CHAR Yearly LT Debt VS Equity VS FCFCHAR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2024 0 20M 40M 60M 80M

2.3 Liquidity

  • CHAR has a Current Ratio of 1.08. This is a normal value and indicates that CHAR is financially healthy and should not expect problems in meeting its short term obligations.
  • CHAR has a Quick Ratio of 1.08. This is a normal value and indicates that CHAR is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 1.08
CHAR Yearly Current Assets VS Current LiabilitesCHAR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2024 100K 200K 300K 400K

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 40.50, CHAR can be considered very expensive at the moment.
  • The average S&P500 Price/Earnings ratio is at 26.68. CHAR is valued rather expensively when compared to this.
Industry RankSector Rank
PE 40.5
Fwd PE N/A
CHAR Price Earnings VS Forward Price EarningsCHAR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CHAR Per share dataCHAR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CHAR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CHARLTON ARIA ACQUISITI-CL A

NASDAQ:CHAR (2/12/2026, 8:00:00 PM)

10.53

-0.01 (-0.09%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-12
Earnings (Next)N/A
Inst Owners92.89%
Inst Owner ChangeN/A
Ins Owners2.49%
Ins Owner Change0%
Market Cap115.41M
Revenue(TTM)N/A
Net Income(TTM)2.90M
AnalystsN/A
Price TargetN/A
Short Float %0.03%
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 40.5
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.33
P/tB 1.33
EV/EBITDA N/A
EPS(TTM)0.26
EY2.47%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS7.93
TBVpS7.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.81
Profitability
Industry RankSector Rank
ROA 3.27%
ROE 3.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.08
Quick Ratio 1.08
Altman-Z 39.64
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CHARLTON ARIA ACQUISITI-CL A / CHAR FAQ

What is the fundamental rating for CHAR stock?

ChartMill assigns a fundamental rating of 1 / 10 to CHAR.


What is the valuation status for CHAR stock?

ChartMill assigns a valuation rating of 0 / 10 to CHARLTON ARIA ACQUISITI-CL A (CHAR). This can be considered as Overvalued.


Can you provide the profitability details for CHARLTON ARIA ACQUISITI-CL A?

CHARLTON ARIA ACQUISITI-CL A (CHAR) has a profitability rating of 0 / 10.


How financially healthy is CHARLTON ARIA ACQUISITI-CL A?

The financial health rating of CHARLTON ARIA ACQUISITI-CL A (CHAR) is 5 / 10.